TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
RNAC

Cartesian Therapeutics Inc.

Healthcare · Biotechnology

6.80$ -5.5% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Cartesian Therapeutics Inc. (RNAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 319 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RNAC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
86 89 74 117 110 101 90 73 60 44 62 47 40 100 89 75 181 165 177 181 167 160 146 188 178 166 156 140 106 305 325 348 455 435 409 389 373 296 288 319
83 87 71 115 107 99 85 69 56 42 60 44 36 97 74 61 167 151 163 167 152 144 130 173 160 148 138 123 90 91 111 125 229 217 185 163 147 129 122 154
59 59 27 83 72 71 58 60 50 37 32 30 34 90 73 60 146 139 125 126 115 114 113 138 113 106 126 112 80 77 103 87 219 213 180 160 143 125 119 148
79 84 69 113 104 97 83 66 50 37 48 42 34 90 73 60 146 139 148 150 139 128 117 142 146 135 126 112 80 77 103 87 219 213 180 160 143 125 119 148
0.5 0.2 0.1 0.0 – 0.1 0.1 – – – – – – 5.0 5.0 – 13 7.2 8.3 8.5 7.3 9.9 7.2 24 6.9 9.8 8.7 6.4 6.8 8.9 4.4 36 5.8 0.9 1.8 0.4 0.7 1.1 0.3 0.2
0.0 0.0 0.0 0.0 0.0 -2.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
2.1 2.0 2.1 2.1 2.1 2.1 2.3 2.1 2.1 2.1 3.0 2.5 2.0 1.5 13 13 1.4 1.4 1.3 12 1.8 2.1 2.7 12 2.9 2.8 2.8 13 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 0.0 – – – 48 48 48 48 48 48 48 48 48 48 48
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – 151 151 151 151 151 151 151 151 94 94 94
20 34 33 39 45 49 48 49 50 50 48 47 44 91 98 88 188 183 196 185 186 137 90 98 93 72 81 74 46 745 442 449 455 442 431 391 409 423 437 444
7.7 14 13 20 11 11 12 14 35 35 33 32 29 35 30 23 77 82 85 87 96 72 39 34 24 25 27 29 20 68 37 26 21 23 15 12 14 15 16 21
2.9 4.1 4.5 4.6 21 21 21 21 21 21 23 23 22 19 18 10 0.9 0.9 1.4 3.3 5.1 7.0 1.8 4.4 7.4 10 12 12 1.8 2.2 2.2 2.5 2.8 2.9 3.7 3.8 3.9 4.2 4.2 4.2
1.0 3.9 1.3 4.3 1.5 1.6 1.8 1.8 1.3 1.1 0.7 2.5 1.5 0.5 1.3 1.2 0.5 0.4 0.6 0.2 1.6 0.2 0.3 0.7 0.2 0.3 1.1 0.3 0.4 3.2 2.5 2.9 0.5 0.3 2.1 0.5 2.2 1.3 1.6 1.0
9.1 8.0 6.9 5.7 21 21 21 21 0.0 – – – – – – 6.4 25 25 25 23 21 20 25 23 20 18 16 14 – – – – – – – – – – – 53
65 55 41 78 65 52 42 24 10 -5.4 15 0.1 -4.9 8.4 -8.8 -13 -7.4 -18 -20 -4.2 -19 23 56 90 85 94 75 65 60 -440 -117 -101 0.8 -6.8 -22 -2.5 -36 -126 -148 -125
-137 -152 -167 -183 -197 -217 -228 -247 -263 -280 -292 -309 -321 -336 -355 -379 -389 -405 -429 -425 -443 -430 -402 -393 -401 -395 -417 -428 -437 -615 -671 -658 -682 -692 -710 -694 -730 -822 -862 -846
0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 1.1 1.2 1.3 1.5 2.6 2.7 2.9 3.0 3.1 3.4 3.8 3.8 4.1 5.0 5.1 4.8 5.1 5.1 5.2 5.2 5.4 18 21 26 26 26 26 26 27 30

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?